SEC Form 4 · accession 0001104659-15-018784
CORGENIX MEDICAL CORP/CO · CONX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brandon Price
Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 11, 2015 · 12:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001063665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| "Right to buy" common stock optionsF1 | $0.215 | Mar 10, 2015 | D | 40,000 | D | Aug 27, 2013 | Aug 27, 2020 | Common Stock | 40,000 | 0 | D |
| "Right to buy" common stock optionsF2 | $0.21 | Mar 10, 2015 | D | 10,000 | D | Aug 27, 2013 | Jul 1, 2020 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Pursuant to its terms, this option is fully vested. Pursuant to the Agreement and Plan of Merger dated as of August 27, 2014, among Corgenix Medical Corp, Centennial Medical Holdings, Inc. and Centennial Integrated, Inc. (the "Merger Agreement"), this stock option was cancelled in the merger in exchange for the right to receive an amount in cash, without interest, equal to the product of the number of shares issuable upon the exercise of such stock option and $0.27 minus the exercise price of such stock option, less any applicable withholding taxes (the "Option Merger Consideration"), which was equal to $2,200.
- F2Pursuant to its terms, this option is fully vested. Pursuant to the Merger Agreement, this stock option was canceled in the merger in exchange for the Option Merger Consideration, which was equal to $600.